Showing results (391-400 of 633) with videos related to

Sort By:
Pageof 64
Skin Health and Disease|April 5, 2024
No-shows to hidradenitis suppurativa clinic visits: Patient perspectivesNatalie M Fragoso, Rahul Masson, Terri Shih, et al.
Skin Health and Disease|October 2, 2024
Novel CYLD pathogenic variant associated with multiple cylindromas of the scalp-A case reportInês P Amaral, Ivânia Soares, Madalena P Correia, et al.
Skin Health and Disease|October 2, 2024
Multiple glomus tumours: Clinical, ultrasonographic and histopathologic findings of a rare diseaseBárbara Wiese, Patricia F Acevedo, Rodrigo A Franceschett, et al.
Skin Health and Disease|October 2, 2024
Real-world experience of using dupilumab and JAK inhibitors to manage pruritus in epidermolysis bullosa pruriginosaPing-Chen Hou, Wilson Aala, Wei-Ting Tu, et al.
Skin Health and Disease|October 2, 2024
A sporadic diffuse multiple cutaneous leiomyomatosis mimicking plexiform neurofibromatosis: A surgical challengeGajanand M Antakanavar, Bijaylaxmi Sahoo, Aneet Kaur, et al.
Skin Health and Disease|October 2, 2024
Linear atrophoderma of Moulin: A rare case report and review of the literatureMoatasem Hussein Al-Janabi, Sdrah Diab, Ghina Aljammal, et al.
Skin Health and Disease|October 2, 2024
Patient experience: Feeling like the tin man from the Wizard of OzCaoimhe Dalton, Lisa Murphy, Carmel Ann Galligan, et al.
Skin Health and Disease|October 2, 2024
Comparing antibiotic prescribing patterns for hidradenitis suppurativa between dermatology and non-dermatology ambulatory providersHannah Tolson, Robin Kikuchi, Rebecca K Yamamoto, et al.
Skin Health and Disease|October 2, 2024
Practice and community nurses' views and experiences of helping people manage risk factors for recurrent lower limb cellulitis: A qualitative interview studyIngrid Muller, Emma Teasdale, Fiona Cowdell, et al.
Skin Health and Disease|October 6, 2023
No impact of disease duration on response to tildrakizumab treatment among patients with moderate-to-severe plaque psoriasis: Post hoc analyses from two phase 3 (reSURFACE 1 and reSURFACE 2) and one phase 4 (TRIBUTE) studiesJohannes Griss, Gudrun Ratzinger, Julia-Tatjana Maul, et al.
Pageof 64